Filter
1765
Text search:
European
centre
for
disease
prevention
and
control
Featured
180
344
Language
Document type
802
381
293
116
59
45
17
17
15
9
5
3
2
1
Countries / Regions
150
84
46
45
36
34
24
24
23
23
23
18
18
16
16
16
15
15
15
14
14
13
12
11
11
9
9
8
8
8
7
7
7
7
7
7
6
6
6
6
6
6
6
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
404
152
120
98
47
22
19
Toolboxes
223
169
159
130
104
80
79
58
51
44
44
43
43
39
37
34
29
26
21
14
12
12
8
7
4
Antibiotic resistance is a natural occurrence caused by mutations in bacteria’s genes. However, inappropriate use of antibiotics accelerates the emergence and spread of antibiotic-resistant bacteria. When exposed to antibiotics, susceptible bacter
...
The ability of bacteria to resist the action of an antibiotic has become a recognised global problem. Antibiotic resistance severely limits the number of antibiotics available for the treatment of diseases.
A patient leaflet for primary care prescribers to hand out to patients: it explains to patients what antibiotic resistance is and why appropriate use of antibiotics is important.
last updated 29 March 2016
ECDC launched the HEPSA (Health Emergency Preparedness Self-Assessment) tool, in order to support countries in improving their level of public health emergency preparedness. The tool is worksheet-based and is targeted at professionals in public heal
...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
This report provides an overview of the progress in the roll-out of COVID-19 vaccines in adults (aged 18 years and above) across EU/EEA Member States. It presents the number of vaccine doses distributed by manufacturers to each Member State
...
European Union Standards for Tuberculosis Care 2017 Estonian Version
European Union Standards for Tuberculosis Care 2017 Update (Romanian Version)
ECDC is now offering a series of micro learning activities related to COVID-19 (the disease causing the 2019 novel coronavirus outbreak). The e-learning activities are available in the ECDC Virtual Academy (EVA). https://eva.ecdc.europa.eu/mod/scorm
...
Basic information about the virus, symptoms, prevention and transmission.
Social distancing is an action taken to minimise contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs)1 aimed at reducing disease transmission
...
This document aims to support public health preparedness planning and response activities on the safe handling of bodies of deceased persons with suspected or confirmed COVID-19: at the site of death, during transport, storage
...
This catalogue provides tools and information resources to support EU/EEA countries in addressing the challenging issue of vaccine hesitancy. The catalogue provides examples of practices that can serve as a resource
...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EE
...
